Robuta

https://www.dkfz.de/en/epigenomik/cancer-chemoprevention-and-epigenomics/molecular-determinants-of-primary-endocrine-resistance-in-luminal-breast-cancer Molecular determinants of primary endocrine resistance in luminal breast cancer - German Cancer... endocrine resistance breast cancer molecular determinants primary https://deceraclinical.com/education/program/oncology/overcoming-et-resistance-in-hrposher2neg-mbc/39956 Overcoming Endocrine Resistance in HR+/HER2- MBC: Tailoring Treatment for Patients With ESR1- and... Gain in-depth knowledge on how to integrate novel and emerging agents into the treatment of patients with HR-positive/HER2-negative MBC and ESR1 or... https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1414392/full Frontiers | Editorial: Resistance to endocrine therapies in cancer, volume II indicator and promising therapeutic target [1][2][3][4]. A small molecule inhibitor of JMDJ6 has shown antitumor efficacies against estrogen receptor (ER)+ B... frontiers editorial resistance endocrine therapies https://pure.eur.nl/en/publications/exploration-and-understanding-of-endocrine-mono-and-combination-t/ Exploration and understanding of endocrine mono- and combination therapy resistance in hormone... combination therapy exploration understanding endocrine https://expertperspectives.com/conference-reporter/cdk4-6-inhibition-and-endocrine-resistance-in-advanced-hr-her2-breast-cancer/ Expert Perspectives | CDK4/6 Inhibition and Endocrine Resistance in Advanced HR+ HER2- Breast Cancer